Expert Review of Neurotherapeutics

Papers
(The H4-Index of Expert Review of Neurotherapeutics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The role of Fecal Microbiota Transplantation (FMT) in treating patients with multiple sclerosis50
The latest developments with internet-based psychological treatments for depression42
Laser interstitial thermal therapy for recurrent brain metastases following stereotactic radiosurgery: a systematic review38
Where Art Thou O treatment for diabetic neuropathy: the sequel36
The relevance of cortical thickness in migraine sufferers and implications to therapy36
Advances in the treatment and management of frontotemporal dementia32
The influence of anxiety and depression on headache in adolescent migraineurs: a case-control study32
How have the recent updated epilepsy classifications impacted on diagnosis and treatment?29
An overview of the differences in the pharmacological management of post-traumatic stress disorder between women and men29
New and emerging pharmacotherapeutic options for the treatment of lennox-gastaut syndrome: moving forward in 202528
Neuroprotective strategies in multiple sclerosis: a status update and emerging paradigms27
Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis25
Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington’s disease24
Does electrical stimulation still have a place in the treatment armamentarium for Bell’s palsy?24
The current status of somatostatin analogs in the treatment of neuroendocrine tumors and future perspectives24
Why is ADHD so difficult to diagnose in older adults?22
Neonatal seizures treatment based on conventional multichannel EEG monitoring: an overview of therapeutic options22
Acute and long-term cognitive impairment following sepsis: mechanism and prevention21
Post Intensive Care Syndrome (PICS): an overview of the definition, etiology, risk factors, and possible counseling and treatment strategies21
Updated review on the link between cortical spreading depression and headache disorders21
Uncertainties in anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: the challenges ahead21
Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents21
0.11785697937012